Cardiol Therapeutics Inc. (CRDL) vs Inogen, Inc. (INGN)
A side-by-side comparison of Cardiol Therapeutics Inc. and Inogen, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CRDL
Cardiol Therapeutics Inc.
$1.30HealthcareDelayed quote: Oct 6, 2026, 2:43 PM EDT
INGN
Inogen, Inc.
$5.80HealthcareDelayed quote: Oct 6, 2026, 2:44 PM EDT
Total return — CRDL vs INGN
growth of $100 · dividends reinvested · last 8yCRDL -64.7% (-12.2%/yr)INGN -95.7% (-32.6%/yr)CRDL compounded faster over this window
Log scale — wide-divergence pair
CRDL INGN
CRDL vs INGN: by the numbers
- •INGN is the larger company ($157M vs $149M market cap).
- •Both run net losses; CRDL's is the smaller (0.00% vs -6.94% net margin).
Metrics side by side
Valuation
| Metric | CRDL | INGN |
|---|---|---|
| P/S ratio | N/A | 0.44 |
| P/B ratio | 8.82 | 0.90 |
Profitability
| Metric | CRDL | INGN |
|---|---|---|
| Gross margin | 0.00% | 48.89% |
| Operating margin | 0.00% | -8.45% |
| Net margin | 0.00% | -6.94% |
| ROE | -155.34% | -14.07% |
| ROIC | -165.56% | -13.94% |
Growth (annualized)
| Metric | CRDL | INGN |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 1.02% |
| Total return CAGR (5Y) | -18.36% | -32.83% |
Frequently asked
- How have CRDL and INGN total returns compared?
- Over the past 5 years, CRDL delivered -18.36% and INGN delivered -32.83% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.